33
/pt/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512562
319423
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Receber premium
Create a timeline
Public timelines
FAQ
About & FeedbackAcordoPrivacidadeFAQ
Support 24/7  
CabinetGet premium
Donate

1 jan 2013 ano - Ado-Trastuzumab Emtansine (T-DM1)

Descrição:

For the treatment of patients with HER2-positive breast cancer previously treated with trastuzumab and/or a taxane drug, the FDA recommends ado-trastuzumab emtansine (T-DM1).

Adicionado na linha do tempo:

Cancer

ByTrinity Ozias
14 nov 2019
0
0
302

Data:

1 jan 2013 ano
Agora
~ 12 years ago
About & FeedbackAcordoPrivacidadeFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL